HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Statistics

Total Valuation

TSX:HLS has a market cap or net worth of CAD 163.88 million. The enterprise value is 223.09 million.

Market Cap	163.88M
Enterprise Value	223.09M

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:HLS has 31.39 million shares outstanding. The number of shares has decreased by -0.86% in one year.

Current Share Class	31.39M
Shares Outstanding	31.39M
Shares Change (YoY)	-0.86%
Shares Change (QoQ)	-0.48%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	10.71%
Float	18.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.13
PB Ratio	1.81
P/TBV Ratio	n/a
P/FCF Ratio	9.44
P/OCF Ratio	9.35
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.84, with an EV/FCF ratio of 12.85.

EV / Earnings	-10.87
EV / Sales	2.90
EV / EBITDA	9.84
EV / EBIT	n/a
EV / FCF	12.85

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.83.

Current Ratio	1.09
Quick Ratio	0.77
Debt / Equity	0.83
Debt / EBITDA	3.34
Debt / FCF	4.36
Interest Coverage	-0.61

Financial Efficiency

Return on equity (ROE) is -20.16% and return on invested capital (ROIC) is -2.24%.

Return on Equity (ROE)	-20.16%
Return on Assets (ROA)	-1.90%
Return on Invested Capital (ROIC)	-2.24%
Return on Capital Employed (ROCE)	-4.25%
Revenue Per Employee	836,417
Profits Per Employee	-223,021
Employee Count	92
Asset Turnover	0.33
Inventory Turnover	2.00

Taxes

In the past 12 months, TSX:HLS has paid 334,146 in taxes.

Income Tax	334,146
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.61% in the last 52 weeks. The beta is 1.11, so TSX:HLS's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+61.61%
50-Day Moving Average	4.96
200-Day Moving Average	4.33
Relative Strength Index (RSI)	65.40
Average Volume (20 Days)	7,435

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:HLS had revenue of CAD 76.95 million and -20.52 million in losses. Loss per share was -0.65.

Revenue	76.95M
Gross Profit	55.67M
Operating Income	-7.04M
Pretax Income	-20.18M
Net Income	-20.52M
EBITDA	22.61M
EBIT	-7.04M
Loss Per Share	-0.65

Balance Sheet

The company has 16.57 million in cash and 75.79 million in debt, giving a net cash position of -59.22 million or -1.89 per share.

Cash & Cash Equivalents	16.57M
Total Debt	75.79M
Net Cash	-59.22M
Net Cash Per Share	-1.89
Equity (Book Value)	90.78M
Book Value Per Share	2.88
Working Capital	3.34M

Cash Flow

In the last 12 months, operating cash flow was 17.53 million and capital expenditures -165,027, giving a free cash flow of 17.36 million.

Operating Cash Flow	17.53M
Capital Expenditures	-165,027
Free Cash Flow	17.36M
FCF Per Share	0.55

Margins

Gross margin is 72.35%, with operating and profit margins of -9.15% and -26.66%.

Gross Margin	72.35%
Operating Margin	-9.15%
Pretax Margin	-26.23%
Profit Margin	-26.66%
EBITDA Margin	29.38%
EBIT Margin	-9.15%
FCF Margin	22.57%

Dividends & Yields

TSX:HLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.86%
Shareholder Yield	n/a
Earnings Yield	-12.52%
FCF Yield	10.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:HLS has an Altman Z-Score of -0.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.94
Piotroski F-Score	4